Blocking ACLY activity reduces the growth of cancer cells both in laboratory settings and living organisms, suggesting that this enzyme could be a promising target for cancer treatment (Hatzivassiliou et al., 2005; Zu et al., 2012). Here, ACLY is linked to cancer.